title: Experimental drug may change the treatment of osteoporosis.  Romosozumab appears to increase bone mineral density and help rebuild the skeleton at the same time.
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D015507:Drugs, Investigational; D006801:Humans; D010024:Osteoporosis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D050071:Bone Density Conservation Agents; D015507:Drugs, Investigational; C557282:romosozumab